trending Market Intelligence /marketintelligence/en/news-insights/trending/VvBZZ_Xj_mwT2cHGjYqv4w2 content esgSubNav
In This List

US FDA approves Anika's bone repair treatment

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


US FDA approves Anika's bone repair treatment

The U.S. Food and Drug Administration approved Anika Therapeutics, Inc.'s injectable bone repair treatment.

The U.S. regulator granted 510(k) clearance to the company's injectable hyaluronic acid-based bone void filler for filling bone voids or defects of the skeletal system.

The bone void filler is resorbed and replaced by the growth of new bone during the healing process.